Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
September 2, 2002
- Korosho Resumes Debates on Production of Blood Products
September 2, 2002
- Janssen's Virtual Hallucination System Used Widely
September 2, 2002
- Human Tissue Transplantation GL Compiled by Society
September 2, 2002
- JPMA to Prepare Guidebook on Electronic Data Capture
September 2, 2002
- Monkasho Initiates Protein 3,000 Project
September 2, 2002
- CMIC to Expand Business in Response to New PAL
September 2, 2002
- REGULATORY NEWS IN BRIEF
September 2, 2002
- FJPWA Asks Korosho to Abolish Recording Lot Numbers
September 2, 2002
- BUSINESS NEWS IN BRIEF
August 26, 2002
- PRESS SEMINAR
August 26, 2002
- BULLETIN -1-
August 26, 2002
- WEBSITE NEWS
August 26, 2002
- GCP Revision to Follow PAL Amendment
August 26, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 26, 2002
- Outline of New NDA Reviewing Institution Revealed
August 26, 2002
- Large Product Line, Reasonable Prices in Drug Stores Are Appreciated: Survey
August 26, 2002
- Korosho to Beef Up Japanese Makers' R&D Competitiveness
August 26, 2002
- 90% of Public Think School Education on Drugs Is Necessary: PAJ Survey
August 26, 2002
- Korosho to Propose More Attractive R&D Taxation System
August 26, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…